Andrea Corsonello1, Claudio Pedone2, Stefania Bandinelli3, Luigi Ferrucci4, Raffaele Antonelli Incalzi2,5. 1. Unit of Geriatric Pharmacoepidemiology, Italian National Research Center on Aging (INRCA), Cosenza, Italy. 2. Unit of Geriatric Medicine, University "Campus Biomedico", Rome, Italy. 3. Healthcare Agency of Florence, Florence, Italy. 4. National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA. 5. "Cittadella della Carità" Foundation, Taranto, Italy.
Abstract
AIM: The aim was to investigate to what extent chronic kidney disease (CKD) can be staged interchangeably by Chronic Kidney Disease Epidemiological Collaboration (CKD-EPI) and by Berlin Initiative Study (BIS) equations, and to verify whether cystatin C can improve concordance between formulas. METHODS: Our series consisted of 828 community-dwelling individuals aged 65 years or older enrolled in the Invecchiare in Chianti Study ("Aging in the Chianti Region"). Estimated glomerular filtration rate was calculated using the creatinine-based CKD-EPI, creatinine/cystatin C-based CKD-EPI, creatinine-based BIS and creatinine/cystatin C-based BIS equations. Agreement and sources of discrepancy between equations in identifying people with different degrees of kidney dysfunction was investigated by κ statistic and Bland-Altman plots. RESULTS: Overall, CKD-EPI values were higher than that obtained with BIS equations, especially for eGFR = 30-60 mL/min/1.73 m2 . A total of 191 out of 828 participants were classified in stage 2 by the creatinine-based CKD-EPI and in stage 3a by the creatinine-based BIS equation, whereas 123 participants were classified in stage 2 by creatinine/cystatin C-based CKD-EPI and in stage 3a by the creatinine/cystatin C-based BIS equation. A total of 27 participants were classified in stage 3a by creatinine-based CKD-EPI and in stage 3b by creatinine-based BIS equation, whereas 18 were classified as stage 3a by creatinine/cystatin C-based CKD-EPI and stage 3b by the creatinine/cystatin C-based BIS equation. CONCLUSIONS: Despite a fair overall concordance, the CKD-EPI and BIS equations cannot be considered interchangeable to assess estimated glomerular filtration rate in older people, and using creatinine/cystatin C-based rather than creatinine-based equations only marginally improves the concordance between CKD-EPI and BIS. Disagreement between equations might significantly impact the applications of stage-specific measures for managing CKD among older people. Geriatr Gerontol Int 2017; 17: 1559-1567.
AIM: The aim was to investigate to what extent chronic kidney disease (CKD) can be staged interchangeably by Chronic Kidney Disease Epidemiological Collaboration (CKD-EPI) and by Berlin Initiative Study (BIS) equations, and to verify whether cystatin C can improve concordance between formulas. METHODS: Our series consisted of 828 community-dwelling individuals aged 65 years or older enrolled in the Invecchiare in Chianti Study ("Aging in the Chianti Region"). Estimated glomerular filtration rate was calculated using the creatinine-based CKD-EPI, creatinine/cystatin C-based CKD-EPI, creatinine-based BIS and creatinine/cystatin C-based BIS equations. Agreement and sources of discrepancy between equations in identifying people with different degrees of kidney dysfunction was investigated by κ statistic and Bland-Altman plots. RESULTS: Overall, CKD-EPI values were higher than that obtained with BIS equations, especially for eGFR = 30-60 mL/min/1.73 m2 . A total of 191 out of 828 participants were classified in stage 2 by the creatinine-based CKD-EPI and in stage 3a by the creatinine-based BIS equation, whereas 123 participants were classified in stage 2 by creatinine/cystatin C-based CKD-EPI and in stage 3a by the creatinine/cystatin C-based BIS equation. A total of 27 participants were classified in stage 3a by creatinine-based CKD-EPI and in stage 3b by creatinine-based BIS equation, whereas 18 were classified as stage 3a by creatinine/cystatin C-based CKD-EPI and stage 3b by the creatinine/cystatin C-based BIS equation. CONCLUSIONS: Despite a fair overall concordance, the CKD-EPI and BIS equations cannot be considered interchangeable to assess estimated glomerular filtration rate in older people, and using creatinine/cystatin C-based rather than creatinine-based equations only marginally improves the concordance between CKD-EPI and BIS. Disagreement between equations might significantly impact the applications of stage-specific measures for managing CKD among older people. Geriatr Gerontol Int 2017; 17: 1559-1567.
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Ciro Esposito; Massimo Torreggiani; Marta Arazzi; Nicoletta Serpieri; Maria Lucia Scaramuzzi; Alessandra Manini; Fabrizio Grosjean; Vittoria Esposito; Davide Catucci; Edoardo La Porta; Antonio Dal Canton Journal: J Gerontol A Biol Sci Med Sci Date: 2012-08-24 Impact factor: 6.053
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Lynda A Szczech; Rebecca C Stewart; Hsu-Lin Su; Richard J DeLoskey; Brad C Astor; Chester H Fox; Peter A McCullough; Joseph A Vassalotti Journal: PLoS One Date: 2014-11-26 Impact factor: 3.240
Authors: Ersilia Paparazzo; Silvana Geracitano; Vincenzo Lagani; Luca Soraci; Annalisa Cozza; Salvatore Cosimo; Francesco Morelli; Andrea Corsonello; Giuseppe Passarino; Alberto Montesanto Journal: Front Med (Lausanne) Date: 2022-04-26
Authors: Andrea Corsonello; Regina Roller-Wirnsberger; Gerhard Wirnsberger; Johan Ärnlöv; Axel C Carlsson; Lisanne Tap; Francesco Mattace-Raso; Francesc Formiga; Rafael Moreno-Gonzalez; Christian Weingart; Cornel Sieber; Tomasz Kostka; Agnieszka Guligowska; Pedro Gil; Sara Lainez Martinez; Rada Artzi-Medvedik; Itshak Melzer; Fabrizia Lattanzio Journal: J Clin Med Date: 2020-01-21 Impact factor: 4.241